tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Avidity, Phathom mentioned as potential takeout targets at Needham
The FlyAvidity, Phathom mentioned as potential takeout targets at Needham
12h ago
BMY
NVO
Novo Nordisk, WeightWatchers expand collaboration
PremiumThe Fly
Novo Nordisk, WeightWatchers expand collaboration
16d ago
NVO
Novo Nordisk misread U.S. market for weight loss drug, Reuters reports
PremiumThe Fly
Novo Nordisk misread U.S. market for weight loss drug, Reuters reports
17d ago
LLY
NVO
Novo Nordisk announces WeightWatchers collaboration for Wegovy
PremiumThe Fly
Novo Nordisk announces WeightWatchers collaboration for Wegovy
22d ago
NVO
Citi sees tiered orforglipron pricing $15B opportunity for Eli Lilly
PremiumThe Fly
Citi sees tiered orforglipron pricing $15B opportunity for Eli Lilly
23d ago
LLY
NVO
California seeks to cut Medicaid coverage for weight loss drugs, Bloomberg says
PremiumThe FlyCalifornia seeks to cut Medicaid coverage for weight loss drugs, Bloomberg says
24d ago
LLY
NVO
Hims & Hers litigation risk ‘back on the table’, says Truist
Premium
The Fly
Hims & Hers litigation risk ‘back on the table’, says Truist
24d ago
NVO
HIMS
Novo Nordisk cites ‘concerns about illegal mass compounding’ in ending Hims pact
Premium
The Fly
Novo Nordisk cites ‘concerns about illegal mass compounding’ in ending Hims pact
24d ago
NVO
HIMS
Video: Northern Trust jumps, Hims & Hers sinks in pre-market trade
PremiumThe Fly
Video: Northern Trust jumps, Hims & Hers sinks in pre-market trade
24d ago
BK
NVO
Morning Movers: Hims & Hers plunges after Wegovy pact termination
PremiumThe Fly
Morning Movers: Hims & Hers plunges after Wegovy pact termination
24d ago
FI
CMC
Hims & Hers downgraded, removed from Conviction List at Needham after Novo news
PremiumThe Fly
Hims & Hers downgraded, removed from Conviction List at Needham after Novo news
24d ago
LLY
NVO
U.S. strikes Iran nuclear sites, Novo terminates Hims & Hers deal: Morning Buzz
PremiumThe Fly
U.S. strikes Iran nuclear sites, Novo terminates Hims & Hers deal: Morning Buzz
24d ago
BK
AMD
Hims & Hers legal risk up ‘substantially’ with cancellation, says Citi
PremiumThe FlyHims & Hers legal risk up ‘substantially’ with cancellation, says Citi
24d ago
LLY
NVO
Hims & Hers CEO ‘disappointed,’ says Novo Nordisk ‘misleading the public’
Premium
The Fly
Hims & Hers CEO ‘disappointed,’ says Novo Nordisk ‘misleading the public’
24d ago
NVO
HIMS
Hims & Hers plunges after Novo Nordisk terminates collaboration
Premium
The Fly
Hims & Hers plunges after Novo Nordisk terminates collaboration
24d ago
NVO
HIMS
Novo Nordisk terminates collaboration with Hims & Hers Health
PremiumThe Fly
Novo Nordisk terminates collaboration with Hims & Hers Health
24d ago
NVO
HIMS
Sciwind Biosciences showcases challenger to obesity drugs, Bloomberg says
PremiumThe Fly
Sciwind Biosciences showcases challenger to obesity drugs, Bloomberg says
25d ago
LLY
NVO
Novo Nordisk presented results from its Phase 3b FRONTIER5 trial on Mim8
PremiumThe Fly
Novo Nordisk presented results from its Phase 3b FRONTIER5 trial on Mim8
25d ago
NVO
Novo Nordisk announces REDEFINE 1 trial of CagriSema met co-primary endpoints
PremiumThe Fly
Novo Nordisk announces REDEFINE 1 trial of CagriSema met co-primary endpoints
25d ago
NVO
Novo Nordisk price target lowered to $90 from $110 at Argus
PremiumThe FlyNovo Nordisk price target lowered to $90 from $110 at Argus
27d ago
NVO
Prothena announces corporate restructuring, cuts 63% of workforce
Premium
The Fly
Prothena announces corporate restructuring, cuts 63% of workforce
29d ago
BMY
NVO
LifeMD price target raised to $18 from $15 at BTIG
Premium
The Fly
LifeMD price target raised to $18 from $15 at BTIG
30d ago
LLY
NVO

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >